Bürkert Fluid Control Systems’ Post

Members of BioPhorum Technology Strategy’s Control Strategy Framework team recently took part in a workshop focusing on what needs to be done to enhance control strategies via digitization by identifying key pain points, prioritizing and agreeing actions. Today, control strategies are often narrative based and have many associated pain points and inefficiencies. There is a drive towards enhancing control strategies via digitization, however the pathway is not clear. During the workshop, our industry leading-biomanufacturer members identified what the key issues are today and discussed how we they can be mitigated in the future with digitization. This will be the foundation for our forthcoming positioning paper on digitizing control strategies. If you would like to find out more about BioPhorum membership visit: https://lnkd.in/d9i8Edvm  If you are a BioPhorum member and would like to join the Control Strategy Framework team, please contact Robert.elliott@biophorum.com to register your interest. #biopharma #biophorum #techstrategy #pharma #lifesciences #biotechnology #technologystrategy #biotech #digitaltransformation #ectd #regulatoryaffairs #GMP 

#OneWeekToGo for #BioIntegrates2024. Book with BioPartner UK for 25% off: https://lnkd.in/edXwxNde Engage with top executives in #biotech, #CDMO, #supplychain, and #funding & investment to discuss the major challenges impacting the Biotech sector. #Events2024 #Lifesciences #Pharma #Healthcare Life Science Integrates

The wait is finally over.....one day to go! Preparations are in full swing to welcome you to Hall 9, Stall 9C47. Stay tuned for more updates as we prepare for this exciting event. Let's embark on this journey and create a new business relationship !! #machinfabrik #engineering #exhibition #pmec #invitation #pharmaceuticalindustry #manufacturing #exportquality #Steamsterilizer #biotechnology #pharmaceuticalequipment #pharmaceuticalmanufacturing #technology #innovation #quality #pmec2024

Bruce Booth & Atlas Venture are out with their annual year-in-review for #biotech & #pharma. As usual, it's full of interesting stuff, but I was really struck by this slide that shows the hill biopharma companies are climbing. Over the past decade, the average cost to develop a therapy is up by $1 billion. At the same time, success rates have fallen, as has the average value of an approved drug. The science right now is incredibly exciting. Crossed fingers that the other variables required for success -- regulatory frameworks, IP protection, interest rates, etc. -- incentivize break through treatments in 2025 and beyond. The whole presentation is worth your time. https://lnkd.in/eEzQEwDK Recommended, Biorasi!

Is single use technology playing on your mind? Implementing single use process steps can be overwhelming; what design do i need? Do i have the right components? What impact will this have on my molecule? Is this compliant? What the %$&^ is PUPSIT!? From cell to vial we have the expertise to support you on your journey. Read our article on Select Science for tips and strategies on single-use technology from our experienced specialists. You'll discover the advantages of single-use solutions across upstream and downstream processes, and deep dive into the potential sustainability benefits. https://lnkd.in/eSV3fdua #SingleUseTechnologies #Sustainability #Biopharma #Biotech

📢 Feel the fluidic competence at the #ACHEMA2024 Bürkert Fluid Control Systems #wemakeideasflow

India has emerged as a biomanufacturing hub and has proved the competencies during COVID 19 by supplying vaccines to the globe. Join me in a panel discussion to uncover the future potential of innovation, collaboration and outsourcing... #BIO2024 #Biosimilars #biotech #Pharmaceutical Manufacturing

"How to handle biomanufacturing?" 📢 This important question was answered by Dr Adriana Kiędzierska - Mencfeld, our Chief Integration Officer, at CEBioForum 2024 conference. Adriana shared her knowledge and extensive experience in #biomanufacturing during today's discussion panel. 🎤 "Development of biosimilar drugs is an very expensive and time-consuming process.  A company's market advantage will be determined by its ability to delivery product to the market with proper COGS, reflecting price erosion.  We can achieve this through process intensification. Remember, when we talk about a company's market advantage, we are also talking about increasing the availability of a particular biological drug for patients. It's not just about efficiency; it's the essence of our actions”. Thank you to all who joined Adriana in this discussion!    #Biotech #Pharma #Innovation #CEBioforum #Insights Central European BioForum

The Pistoia Alliance recently conducted a survey as a pulse check on which laboratory technologies the #pharma / #biotech industry is investing in and companies' progress integrating new tech into their labs. Check out the key findings in this new article by Becky Upton: https://lnkd.in/euazW9XV #drugdevelopment #advancedtechnologies

Join us for our exclusive webinar on how continuous biomanufacturing can elevate antibody processes! We’ll be diving into a real case study on converting an Intensified Fed-Batch to an Integrated Continuous Bioprocess. In this webinar, learn how you can: • Boost your production efficiency: Find out how our innovative approach resulted in a 5-fold increase in product mass from the bioreactor, significantly enhancing process productivity and output. • Cut costs and increase flexibility: Discover how Integrated Continuous Bioprocessing (ICB) can drastically reduce production costs and offer greater flexibility, making your processes more adaptable to varying production demands and market needs. • Gain expert knowledge: Tap into the extensive expertise of Dr. Brian Follstad, a leading figure in process development with deep insights into the latest advancements in bioprocessing technologies. Secure your spot here: https://hubs.ly/Q02FlQsn0 #researchneverstops #JustEvotecBiologics #Biotech #Pharma #ContinuousBiomanufacturing #Bioprocessing